抗线粒体抗体M2亚型与原发性胆汁性肝硬化

刘秋香; 朴云峰

抗线粒体抗体M2亚型与原发性胆汁性肝硬化

详细信息

中图分类号: R575.2
计量
- 文章访问数: 3190
- HTML全文浏览量: 3
- PDF下载量: 1231
- 被引次数: 0
出版历程
- 出版日期: 2008-02-20

摘要

HTML全文

参考文献(17)

[1]姜小华, 仲人前.原发性胆汁性肝硬化特异性AMA-M2抗体在5011名体检者中的筛查分析[J].中华检验医学杂志, 2003, 26 (9) ∶553~555.

[2]Heathcote EJ.Management of primary biliary cirrhosis[J].Hepatolo-gy, 2000, 31 (4) ∶1005~1013.

[3]姜小华, 仲人前, 屠小卿, 等.人源M2三联体靶抗原检测抗体诊断原发性胆汁性肝硬化[J].中华肝脏病杂志, 2002, 10 (5) ∶341~343。

[4]Berg CP, Stein GM, Klein R, et al.Demonstration of PDC-E1subunits as major antigens in the complement-fixing fraction M4 andre-evaluation of PDC-E1-specific antibodies in PBC patients[J].Liver Int.2006, 26 (7) ∶846-855.

[5]姜小华, 仲人前, 孔宪涛.原发性胆汁性肝硬化发病机制研究进展[J].中国免疫学杂志, 2002, 18 (8) ∶586~589.

[6]Metcalf JV, Mitchison HC, Palmer J, et al.Natural history of earlyprimary biliary cirrhosis[J].Lancet, 1996, 348 (9039) ∶1399~1402.

[7]Zuber MA, Recktenwald C.Clinical correlation of antimitochondrialantibodies[J].Eur J Med Res.2003, 8 (2) ∶61~70.

[8]Masuda J, Omagar K, Miyakawa H, et al.Clinical significance ofpositive immunoblotting but negative immunofluorescence for antimi-tochondrial antibodies in patients with liver diseases other than prima-ry biliary cirrhosis[J].Autoimmunity, 2002, 35 (2) ∶135~141.

[9]Koizumi H, Onozuka Y, Shibata M, et al.Positive rate of antimito-chondrial antibody in Japanese corporate workers[J].Rinsho Byori, 2000, 48 (10) ∶966~970.

[10]Dr Paolo M.‘True’antimitochondrial antibody-negative primarybiliary cirrhosis, lowsensitivity of the routine assays, or both?[J].Clinical&Experimental Immunology, 2004, 135 (1) ∶154~158.

[11]Gabeta S, Norman GL, Liaskos C, et al.Diagnostic Relevance andClinical Significance of the New Enhanced Performance M2 (MIT3) ELISA for the Detection of IgAand IgG Antimitochondrial Antibodiesin Primary Biliary Cirrhosis[J].J Clin Immunol, 2007, 27 (4) ∶378~387.

[12]Oertelt S, Rieger R, Selmi C, et al.A sensitive bead assay for an-timitochond rial antibodies:Chipping away at AMA-negative prima-ry biliary cirrhosis[J].Hepatology, 2007, 45 (3) ∶659~665.

[13]姚定康, 谢渭芬.抗线粒体抗体及其分型对原发性胆汁性肝硬化的诊断价值[J].中华肝脏病杂志, 2005, 13 (1) ∶9-11.

[14]唐乐, 闫惠平, 冯霞, 等.原发性胆汁性肝硬化患者线粒体抗体亚型[J].中国实验诊断学, 2006, 10 (6) ∶621~623.

[15]Wesierska-Gadek J, Penner E, Battezzati PM, et al.Correlationof initial autoantibody profile and clinical outcome in primary biliarycirrhosis[J].Hepatology, 2006, 43 (5) ∶1135~1144.

[16]Klein R, Pointner H, Zilly W, et al.Antimitochondrial antibodyprofiles in primary biliary cirrhosis distinguish at early stages betweena benign and a progressive course:a prospective study on 200 pa-tients followed for 10 years[J].Liver, 1997, 17 (3) ∶119~128.

[17]Robert F, Maria P, Danuta P, et al.High concentration of antimi-tochondrial antibodies predicts progressive primary biliarycirrhosis[J].World J Gastroenterol, 2005, 11 (36) ∶5706~5709.

施引文献

资源附件(0)

访问统计